Literature DB >> 18404969

Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers.

M Martha Vela-Huerta1, Edgar Ulises San Vicente-Santoscoy, Juan Manuel Guizar-Mendoza, Norma Amador-Licona, Carlos Aldana-Valenzuela, Javier Hernnández.   

Abstract

BACKGROUND: It has been suggested that hyperleptinemia could be caused by hyperinsulinemia in infants of diabetic mothers (IDMs). AIM: To compare leptin, insulin, and glucose levels in large-for-gestational-age (LGA) and appropriate-for-gestational-age (AGA) infants.
METHODS: A cross-sectional study was conducted in IDMs, infants of non-diabetic mothers (INDM) and AGA infants.
RESULTS: Seventy-seven newborns were studied (11 IDM, 16 INDM, and 50 AGA infants). Leptin levels were significantly higher in LGA infants than in the AGA group and a trend for higher levels in IDM than NIDM was observed. Insulin levels and insulin resistance were significantly higher in IDMs. Glucose levels were lower in both groups of LGA infants.
CONCLUSIONS: We found insulin resistance, hyperinsulinism and hyperleptinemia in IDMs, and the trend of higher leptin levels in IDMs than INDMs shows that leptin could be related to insulin resistance in these infants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18404969     DOI: 10.1515/jpem.2008.21.1.17

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  11 in total

1.  Analysis of phosphatidylinositol 3-kinase activation in the adipose tissue of gestational diabetes mellitus patients and insulin resistance.

Authors:  Yongli Chu; Wenjuan Liu; Qing Cui; Guijiao Feng; Yan Wang; Xueqiang Jiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

Review 2.  Fetal origins of adult disease.

Authors:  Kara Calkins; Sherin U Devaskar
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2011-07

3.  Investigation of the correlation between 100 gram oral glucose tolerance test results and maternal leptin levels during pregnancy.

Authors:  Ozlem Baykara Sengül; Tamer Mungan; Evrim Erdemoğlu; Göksel Islamoğlu; Nuran Kıyak
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-09-01

4.  Influence of maternal hyperglycemia on IL-10 and TNF-α production: the relationship with perinatal outcomes.

Authors:  Jusciele Brogin Moreli; Glilciane Morceli; Ana Karina C De Luca; Claudia G Magalhães; Roberto A A Costa; Débora Cristina Damasceno; Marilza Vieira Cunha Rudge; Iracema Mattos Paranhos Calderon
Journal:  J Clin Immunol       Date:  2011-12-30       Impact factor: 8.317

5.  Infant obesity and severe obesity growth patterns in the first two years of life.

Authors:  Lisaann S Gittner; Susan M Ludington-Hoe; Harold S Haller
Journal:  Matern Child Health J       Date:  2014-04

6.  Breast milk hormones and regulation of glucose homeostasis.

Authors:  Francesco Savino; Stefania Alfonsina Liguori; Miriam Sorrenti; Maria Francesca Fissore; Roberto Oggero
Journal:  Int J Pediatr       Date:  2011-05-05

Review 7.  Dietary intakes and leptin concentrations.

Authors:  Vajiheh Izadi; Sahar Saraf-Bank; Leila Azadbakht
Journal:  ARYA Atheroscler       Date:  2014-09

Review 8.  From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines.

Authors:  Chiara Sartori; Pietro Lazzeroni; Silvia Merli; Viviana Dora Patianna; Francesca Viaroli; Francesca Cirillo; Sergio Amarri; Maria Elisabeth Street
Journal:  Mediators Inflamm       Date:  2016-09-26       Impact factor: 4.711

9.  Systemic and placental leptin and its receptors in pregnancies associated with obesity.

Authors:  Pai-Jong Stacy Tsai; James Davis; Gillian Bryant-Greenwood
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

10.  Insulin and Leptin Levels in Appropriate-for-Gestational-Age Infants of Diabetic Mother.

Authors:  Ma Martha Vela-Huerta; Norma Amador-Licona; Susana Anaya-Aguirre; Juan Manuel Guizar-Mendoza; Ana Velazquez-Bustamante; Blanca Murillo-Ortiz
Journal:  Iran J Pediatr       Date:  2012-12       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.